Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. (Gut, 2010)

(untitled) - Sandborn, W; Colombel, J; Frankel, M; Hommes, D; Lowder, J; Mayer, L; Plevy, S; Stokkers, P; Travis, S; Van Assche, G; Baumgart, D; Targan, SR